These results indicate that SAR1A overexpression promotes the proliferation of HNSCC cells via the PAM signaling pathway, whereas the suppression of the PI3K/AKT pathway reverses these effects on HNSCC cell proliferation. The gene discussed is SAR1A; the disease is head and neck squamous cell carcinoma.